The programmed cell death receptor/programmed cell death ligand 1 (PD-1/PD-L1) axis is a known pathway exploited by neoplasms to evade immune surveillance (17, 18), inhibition of which has demonstrated clinical efficacy in melanoma and malignancies of the lung (19, 20). This evidence concerns the gene CD274 and neoplasm.